Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Market Could Exceed $2 Billion, Equity Researcher Reports



EW YORK--The market for bioinformatics tools, services, and databases could exceed $2 billion within five years, according to a report written by Jason Reed, an equity research analyst at Oscar Gruss. The report, "Trends in Commercial Bioinformatics," predicted that bioinformatics will become an increasingly important competitive differentiator for public and private life science companies. Market expansion will be driven by explosive growth in genomic research as well as by the weaknesses of available analysis tools and databases, Reed said.

Reed estimated that more than 50 companies make up the bioinformatics industry. He reported that most sales in the area today come from database providers and software/tools suppliers, but added that enterprise IT providers should "garner a larger portion of the industry’s total sales, driven by a great need for integration of the various databases/tools with R&D efforts."

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.